Hi Gyan,
We should wait for the results to come out. It is also possible that they would have shipped most of the quantities during Q1FY16 including pre launch quantities.
Let's do some maths here:
Abilify pre genericization had US sales of USD 7.80 billion (source Otsuka and BMS results). Let's conservatively assume its USD 5 billion. Assuming 50% decline in the prices (much more than 20 - 25% currently), the total market size remains at USD 2.50 billion. Torrent has market share of 10% and should report around USD 225 million sales for FY16.